Comparison 5. Intramuscular ceftriaxone versus intravenous cephazolin.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates	1	117	Risk Ratio (M‐H, Fixed, 95% CI)	1.04 [0.97, 1.11]
2 Recurrent infection	1	102	Risk Ratio (M‐H, Fixed, 95% CI)	0.72 [0.17, 3.06]
3 Preterm delivery	1	102	Risk Ratio (M‐H, Fixed, 95% CI)	0.58 [0.15, 2.29]
4 Admission to neonatal intensive care unit	1	102	Risk Ratio (M‐H, Fixed, 95% CI)	1.05 [0.51, 2.16]
5 Need for change of antibiotic	1	117	Risk Ratio (M‐H, Fixed, 95% CI)	1.97 [0.37, 10.32]
6 Indicence of prolonged pyrexia	1	117	Risk Ratio (M‐H, Fixed, 95% CI)	1.47 [0.44, 4.96]